ArticleEuropean journal of translational myology2026
Electrical stimulation in the therapy of dysphagia: current knowledge - a narrative review.
Article in European journal of translational myology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dysphagia, a sensorimotor disorder impairing swallowing, affects millions globally, compromising quality of life and increasing risks of malnutrition, aspiration pneumonia, and healthcare costs. Neuromuscular Electrical Stimulation (NMES) is an emerging adjunctive therapy delivering low-frequency electrical impulses to stimulate swallowing muscles, enhancing strength, coordination, and neuroplasticity. This narrative review synthesizes evidence on NMES efficacy in dysphagia treatment across pediatric and adult populations, emphasizing muscle-specific outcomes and translational myology applications. In pediatric patients with primary or neurological dysphagia, NMES improves suprahyoid, facial, and tongue muscle activation, enhances swallowing efficiency and reduces tube-feeding dependency In adults, particularly post-stroke, NMES improves laryngeal elevation, Upper Esophageal Sphincter (UES) opening, and quality of life, though efficacy in head and neck cancer patients is limited. Methodological limitations, including small sample sizes, protocol heterogeneity, and lack of assessor blinding, hinder generalizability. NMES is safe, with minor adverse effects such as erythema and holds promise as a valuable adjunct in dysphagia rehabilitation, but requires standardized protocols and robust trials to optimize its role in clinical myology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.